UPDATED Dec 23, 2025
Discover large cap Norwegian Pharmaceuticals & Biotech companies that are on the OSEAX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PHO | NOK 68.60 | 4.7% | 7.4% | NOK 1.8b | NOK 80.50 | PE861.8x | E133.8% | 0% | ||
TRMED | NOK 5.15 | 22.0% | 93.6% | NOK 1.8b | n/a | PS18235x | n/a | n/a | ||
AZT | NOK 21.80 | 5.8% | 62.7% | NOK 1.1b | NOK 32.00 | PE154.6x | E76.0% | n/a | ||
VISTN | NOK 20.40 | 0% | -13.9% | NOK 904.6m | n/a | PE11.6x | n/a | 6.1% | ||
NYKD | NOK 2.34 | 0.8% | -22.5% | NOK 764.1m | n/a | PS10.3x | E-27.6% | 41.2% | ||
HBC | NOK 1.36 | 0% | -15.0% | NOK 678.5m | n/a | PS2.7x | n/a | n/a | ||
LYTIX | NOK 9.88 | 0.8% | 65.8% | NOK 674.4m | NOK 15.00 | PS1788.9x | S142.3% | n/a | ||
NAVA | NOK 23.10 | -9.4% | -9.1% | NOK 554.0m | NOK 36.00 | PS1x | E121.1% | n/a | ||
NORD | NOK 100.00 | 21.7% | 25.0% | NOK 513.2m | n/a | PE4.1x | n/a | 26.0% | ||
ZLNA | NOK 14.70 | 31.3% | n/a | NOK 300.7m | n/a | PS5673.1x | E-24.0% | n/a | ||
ONCIN | NOK 0.47 | -5.3% | n/a | NOK 210.7m | n/a | PS10.5x | n/a | n/a | ||
CRNA | NOK 1.18 | -1.2% | 62.4% | NOK 168.9m | n/a | PE-25.6x | E74.4% | n/a | ||
SOFTX | NOK 0.061 | 6.3% | 238.9% | NOK 145.8m | n/a | PS10.7x | n/a | n/a | ||
EXTX | NOK 1.47 | -5.2% | -61.1% | NOK 93.0m | n/a | PB1.4x | n/a | n/a | ||
ABS | NOK 3.24 | -11.5% | 69.6% | NOK 87.0m | n/a | PS1.9x | E94.8% | n/a | ||
PCIB | NOK 0.25 | -7.4% | -80.8% | NOK 9.3m | n/a | PS2x | n/a | n/a |